Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/14673
Title: | The cardiac atrial appendage stem cell: a new and promising candidate for myocardial repair. | Authors: | KONINCKX, Remco Daniels, Annick WINDMOLDERS, Severina Mees, Urbain Macianskiene, Regina Mubagwa, Kanigula STEELS, Paul Jamaer, Luc Dubois, Jasperina ROBIC, Boris HENDRIKX, Marc RUMMENS, Jean-Luc HENSEN, Karen |
Issue Date: | 2013 | Source: | CARDIOVASCULAR RESEARCH, 97 (3), p. 413-423 | Abstract: | AIMS: Considerable shortcomings in the treatment of myocardial infarction (MI) still exist and therefore mortality remains high. Cardiac stem cell (CSC) therapy is a promising approach for myocardial repair. However, identification and isolation of candidate CSCs is mainly based on the presence or absence of certain cell surface markers, which suffers from some drawbacks. In order to find a more specific and reliable identification and isolation method, we investigated whether CSCs can be isolated based on the high expression of aldehyde dehydrogenase (ALDH). METHODS AND RESULTS: An ALDH(+) stem cell population, the cardiac atrial appendage stem cells (CASCs), was isolated from human atrial appendages. CASCs possess a unique phenotype that is clearly different from c-kit(+) CSCs but that seems more related to the recently described cardiac colony-forming-unit fibroblasts. Based on immunophenotype and in vitro differentiation studies, we suggest that CASCs are an intrinsic stem cell population and are not mobilized from bone marrow or peripheral blood. Indeed, they possess a clonogenicity of 16% and express pluripotency-associated genes. Furthermore, compared with cardiosphere-derived cells, CASCs possess an enhanced cardiac differentiation capacity. Indeed, differentiated cells express the most important cardiac-specific genes, produce troponin T proteins, and have an electrophysiological behaviour similar to that of adult cardiomyocytes (CMs). Transplanting CASCs in the minipig MI model resulted in extensive cardiomyogenic differentiation without teratoma formation. CONCLUSION: We have identified a new human CSC population able to differentiate into functional CMs. This opens interesting perspectives for cell therapy in patients with ischaemic heart disease. | Keywords: | aldehyde dehydrogenase; cardiac stem cells; cardiac differentiation; myocardial infarction | Document URI: | http://hdl.handle.net/1942/14673 | ISSN: | 0008-6363 | e-ISSN: | 1755-3245 | DOI: | 10.1093/cvr/cvs427 | ISI #: | 000315048200004 | Category: | A1 | Type: | Journal Contribution | Validations: | ecoom 2014 |
Appears in Collections: | Research publications |
Show full item record
SCOPUSTM
Citations
40
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
54
checked on Aug 5, 2024
Page view(s)
84
checked on Jun 14, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.